BIVM-ERCC5
Basic information
Region (hg38): 13:102799110-102875994
Links
Phenotypes
GenCC
Source: 
ClinVar
This is a list of variants' phenotypes submitted to 
- not provided (251 variants)
 - Xeroderma pigmentosum, group G (131 variants)
 - Hereditary cancer-predisposing syndrome (72 variants)
 - not specified (64 variants)
 - Cerebrooculofacioskeletal syndrome 3 (26 variants)
 - Inborn genetic diseases (19 variants)
 - Xeroderma pigmentosum (12 variants)
 - Ovarian cancer (10 variants)
 - Cerebrooculofacioskeletal syndrome 3;Xeroderma pigmentosum, group G (7 variants)
 - Xeroderma pigmentosum group G/Cockayne syndrome (4 variants)
 - Xeroderma pigmentosum, group G;Cerebrooculofacioskeletal syndrome 3 (4 variants)
 - Xeroderma pigmentosum-Cockayne syndrome complex (1 variants)
 - See cases (1 variants)
 - ERCC5-related condition (1 variants)
 - 8 conditions (1 variants)
 - Hepatoblastoma (1 variants)
 
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BIVM-ERCC5 gene is commonly pathogenic or not. These statistics are base on transcript: . Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 10 | 64 | 80 | |||
| missense | 122 | 31 | 169 | |||
| nonsense | 12 | |||||
| start loss | 0 | |||||
| frameshift | 13 | 24 | ||||
| splice donor/acceptor (+/-2bp) | 16 | |||||
| Total | 22 | 21 | 144 | 98 | 16 | 
Highest pathogenic variant AF is 0.0000394291
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| BIVM-ERCC5 | protein_coding | protein_coding | ENST00000602836 | 21 | 65045 | 
| pLI Probability LOF Intolerant  | pRec Probability LOF Recessive  | Individuals with no LOFs  | Individuals with Homozygous LOFs  | Individuals with Heterozygous LOFs  | Defined | p | 
|---|---|---|---|---|---|---|
| 1.28e-15 | 1.00 | 125664 | 0 | 84 | 125748 | 0.000334 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.602 | 691 | 737 | 0.938 | 0.0000408 | 9106 | 
| Missense in Polyphen | 265 | 300.98 | 0.88045 | 3663 | ||
| Synonymous | 0.990 | 256 | 277 | 0.924 | 0.0000167 | 2601 | 
| Loss of Function | 3.65 | 36 | 68.6 | 0.525 | 0.00000351 | 847 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.000527 | 0.000527 | 
| Ashkenazi Jewish | 0.00 | 0.00 | 
| East Asian | 0.000218 | 0.000217 | 
| Finnish | 0.000149 | 0.000139 | 
| European (Non-Finnish) | 0.000389 | 0.000387 | 
| Middle Eastern | 0.000218 | 0.000217 | 
| South Asian | 0.000654 | 0.000653 | 
| Other | 0.00 | 0.00 | 
dbNSFP
Source: 
- Pathway
 - Nucleotide excision repair - Homo sapiens (human) 
(Consensus)  
Gene ontology
- Biological process
 - nucleotide-excision repair, DNA incision, 3'-to lesion
 - Cellular component
 - nucleus
 - Molecular function
 - single-stranded DNA binding;endodeoxyribonuclease activity